SEMA6B and neoplasm: Hence, accumulating evidence suggests that SEMA6B may contribute to tumor development by both attenuation of tumor-specific cytotoxic T-cell responses and induction of an immunosuppressive state (Kigel and Rabinowicz 2011; Ge and Li 2013; Cui and Bian 2021).